Workflow
SecureTech Engages Craft Capital Management to Accelerate Capital Formation, National Exchange Uplisting, and Strategic M&A Growth
Globenewswire· 2025-08-14 12:30
Roseville, Minnesota, Aug. 14, 2025 (GLOBE NEWSWIRE) -- SecureTech Innovations, Inc. (OTCQB: SCTH), a pioneering technology company advancing artificial intelligence, industrial 3D printing and manufacturing technologies, cybersecurity, and digital infrastructure solutions, is pleased to announce its engagement of Craft Capital Management, LLC as its exclusive investment banking partner. Craft Capital will support SecureTech’s capital markets strategy, including a bridge financing round, planned uplisting t ...
scPharmaceuticals Receives Notice of Allowances of Multiple US Patent Applications Covering SCP-111
Globenewswire· 2025-08-14 12:30
BURLINGTON, Mass., Aug. 14, 2025 (GLOBE NEWSWIRE) -- scPharmaceuticals Inc. (Nasdaq: SCPH) (the “Company”), a pharmaceutical company committed to revolutionizing cardiorenal healthcare through patient-centric innovations, announced today that it has received five Notices of Allowance from the United States Patent and Trademark Office (USPTO) for patent applications covering their latest furosemide formulation, SCP-111. The SCP-111 formulation is the subject of a supplemental NDA expected to be filed by the ...
Tiziana Life Sciences Doses First Patient in Phase 2a Trial of Intranasal Foralumab for Multiple System Atrophy
Globenewswire· 2025-08-14 12:30
BOSTON, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with its lead development candidate, intranasal foralumab, a fully human, anti-CD3 monoclonal antibody, today announced that the first participant has been enrolled and dosed in its Phase 2a clinical trial evaluating intranasal foralumab in patients living with Multiple System Atrophy (MSA) at Brigham and Women’s Hospita ...
Respected VMS Expert, Economic Geologist Dr. Stephen Piercey Joins Callinex’s Technical Team
Globenewswire· 2025-08-14 12:30
Core Viewpoint - Callinex Mines Inc. has appointed Dr. Stephen Piercey, an experienced geologist specializing in volcanogenic massive sulphide (VMS) deposits, to enhance its technical team and advance the Point Leamington Project in Newfoundland [2][3]. Company Overview - Callinex Mines Inc. is focused on developing a portfolio of base and precious metals deposits in established Canadian mining jurisdictions, with a significant emphasis on the Point Leamington Deposit, which is located in a rich VMS and Gold District in Canada [9]. - The company has reported a pit constrained Indicated Mineral Resource of 5.0 million tonnes grading 2.5 g/t AuEq, equating to 402,000 ounces of AuEq, and an Inferred Mineral Resource of 13.7 million tonnes grading 2.24 g/t AuEq, equating to 986,500 ounces of AuEq [9]. Appointment of Dr. Stephen Piercey - Dr. Piercey brings over 25 years of experience in VMS deposits and has worked in some of Canada's most prolific VMS districts [2][3]. - His expertise is expected to significantly enhance the exploration efforts at the Point Leamington Project, which has not been fully evaluated with modern integrated exploration approaches [3][7]. - Dr. Piercey has received multiple awards, including the Duncan R. Derry Medal, recognizing his contributions to economic geology in Canada [4][5]. Exploration and Development Focus - The company aims to utilize a modern integrated exploration approach to drive resource growth at the Point Leamington project, with Dr. Piercey providing oversight in the next stages of exploration [7]. - The Point Leamington deposit is noted for its high tonnage potential and geological similarities to other productive VMS districts globally, indicating significant exploration opportunities [3][9].
Toppoint Holdings Inc. Reports Second Quarter 2025 Results; Import and Metal Expands
Globenewswire· 2025-08-14 12:23
Waste paper remains the largest revenue and volume driver; imports and metals continue to scale North Wales, PA, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Toppoint Holdings Inc. (NYSE American: TOPP) (“Toppoint” or the “Company”), a truckload services and logistics provider focused on the recycling export supply chain, today announced financial results for the second quarter ended June 30, 2025. Second Quarter 2025 Highlights Revenue: $3.97 million (Q2’25) vs. $4.70 million (Q2’24).Commodity momentum: metals grew ...
United Arab Emirates Ministry of Health and Prevention Approves Biomerica's Fortel® Ulcer Test for Home Use
Globenewswire· 2025-08-14 12:19
10-minute home test enables detection of Helicobacter pylori, a leading cause of peptic ulcers, dyspepsia, and gastric cancerH. pylori linked to approximately 80% of gastric cancer cases; classified as a Class 1 carcinogen by the World Health OrganizationGastric cancer ranks as the fifth most common cancer globally and the fourth leading cause of cancer-related deaths IRVINE, Calif., Aug. 14, 2025 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA), a global provider of advanced diagnostic solutions, today a ...
Biotricity Reinforces Growth Trajectory, Kicking Off Fiscal 2026 with Strong First Quarter Results Featuring Revenue Growth, Positive EBITDA and Improved Margins
Globenewswire· 2025-08-14 12:15
REDWOOD CITY, CA, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Biotricity Inc. (OTCQB:BTCY) ("Biotricity" or the "Company”), an innovative Technology-as-a-Service (TaaS) company committed to redefining the landscape of the healthcare industry with state-of-the-art remote monitoring and diagnostic solutions, today announced its financial results for its first quarter of fiscal 2026, ended June 30, 2025. Dr. Waqaas Al-Siddiq, Biotricity Founder & CEO, said, "We’re proud to deliver another quarter of strong performance a ...
Nuwellis, Inc. Reports Second Quarter 2025 Financial Results and Business Highlights
Globenewswire· 2025-08-14 12:15
MINNEAPOLIS, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a commercial-stage medical technology company dedicated to transforming care for fluid overload patients, today announced financial results for the second quarter ended June 30, 2025, and provided a business update. Second Quarter 2025 and Recent Business Highlights Nuwellis continued to advance its strategic realignment during the second quarter, sharpening focus on high-impact growth areas in pediatric and cardiac surgery care w ...
Polyrizon Regains Compliance with Nasdaq Listing Requirements
Globenewswire· 2025-08-14 12:14
Core Points - Polyrizon Ltd. has regained compliance with Nasdaq listing requirements, allowing it to continue trading under the ticker symbol "PLRZ" [1][2] - The company demonstrated compliance with the minimum bid price requirement as per Nasdaq Listing Rule 5550(a)(2) [2] Company Overview - Polyrizon is a biotechnology company focused on developing intranasal products, specifically innovative medical device hydrogels delivered as nasal sprays [3] - The company's proprietary technology, Capture and Contain TM (C&C), creates a hydrogel-based barrier in the nasal cavity to protect against viruses and allergens [3] - Polyrizon is also developing Trap and Target TM (T&T) technology for the nasal delivery of active pharmaceutical ingredients (APIs) [3]
Maris-Tech to Showcase AI-Powered Video Intelligence and Edge Computing Solutions at DSEI 2025
Globenewswire· 2025-08-14 12:10
Core Viewpoint - Maris-Tech Ltd. is showcasing its advanced AI-powered video intelligence and edge computing solutions at DSEI 2025, emphasizing its commitment to enhancing mission success in defense and homeland security markets [1][2]. Company Overview - Maris-Tech is a global leader in video and AI-based edge computing technology, specializing in intelligent video transmission solutions that address complex encoding-decoding challenges [3]. - The company offers miniature, lightweight, and low-power products that provide high-performance capabilities, including raw data processing, seamless transfer, advanced image processing, and AI-driven analytics [3]. - Founded by veterans of the Israeli technology sector, Maris-Tech serves leading manufacturers in defense, aerospace, intelligence gathering, homeland security, and communication industries [3]. Product Offerings - The company will present several key solutions at DSEI 2025, including: - **Diamond**: A MIL-STD ruggedized situational awareness platform for armored vehicles, offering 360° 3D perimeter coverage and advanced airborne threat detection [5]. - **Jupiter AI**: A miniature, lightweight, low-power AI-based edge computing solution that supports multiple video and AI streams simultaneously [5]. - **Opal**: A MIL-STD ruggedized tactical edge computing solution integrated with AI acceleration and streaming for ground and airborne operations over cellular communication [5]. - **Coral**: A compact and low-power intelligence gathering and tactical platform that supports multiple video streams over cellular communication [5]. - **Firebird F-100 5G**: A low bandwidth, low latency video encoder and decoder for cellular, mesh, and SATCOM networks [5]. Event Participation - Maris-Tech will participate in DSEI 2025, one of the largest defense and security exhibitions globally, taking place from September 9-12, 2025, at Excel London [1][2]. - The company aims to demonstrate its latest innovations that combine AI, edge computing, and advanced video technology to meet the needs of modern defense forces [2].